NCT03323593View on ClinicalTrials.gov

Pharmacokinetics of Different Mode Administration of Intranasal Dexmedetomidine

PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
BioavailabilityDexmedetomidine
Interventions
DRUG

Dexmedetomidine

blood is sampled for quantification of plasma concentration after intravenous, intranasal by atomisation and intranasal by drops.

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT03323593 - Pharmacokinetics of Different Mode Administration of Intranasal Dexmedetomidine | Biotech Hunter | Biotech Hunter